65,437 trials
Schizophrenia
Primary: Change From Baseline in Modified Scale for the Assessment of Negative Symptoms (SANS 1-22 Composite Score) at Week 12 — -13.50; -10.91; -11.21 Score on a Scale — p=0.267
Healthy
Primary: Baseline Corrected Area Under the Concentration-Time Curve From Zero to Last Quantifiable Concentration (AUC 0-t,Adj) for Follicle-Stimulating Hormone (FSH) — 3187.4…
Hereditary Tyrosinemia, Type I
Primary: Maximum Observed Plasma Concentration (Cmax) — 1137.40; 1080.69; 1168.71 ng/mL
Osteoporosis
Primary: Changes in T-cell Activation Measured by Flow Cytometry, Specifically the Percentage of CD3+CD69+ T-cells — 3.6; 1.8 percentage of CD3 positive cells
Congenital Bleeding Disorder · Congenital FXIII Deficiency
Primary: Adverse Events (AEs)(Serious and Non-serious) — 920; 19; 901 Events
Metastatic Gastrointestinal Carcinoid Tumor · Pulmonary Carcinoid Tumor · Recurrent Gastrointestinal Carcinoid Tumor
Primary: Objective Tumor Response Rate (Defined as Partial or Complete Response as Defined by the RECIST Criteria) — 2 participants
Migraine Disorders
Primary: Incidence Rate of Dysphagia — 0.4 events per 1,000 person-months
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks (SVR12) Post-treatment — 80 percentage of participants
Dentin Sensitivity
Primary: Change From Baseline in Schiff Sensitivity Score at Day 14 — 2.70; 2.74; -1.38; -0.10 score on a scale — p=<0.0001
Diphtheria · Tetanus · Acellular Pertussis
Primary: Numbers of Subjects With Any and Grade 3 Solicited Local Symptoms — 105; 55; 40; 1 Participants
Dental Caries
Primary: Percentage of Participants Who Indicate Surgical Intervention — 74 percentage of the dentists
Clear Cell Renal Cell Carcinoma · Stage I Renal Cell Cancer AJCC v6 and v7 · Stage II Renal Cell Cancer AJCC v7
Primary: Disease-free Survival (DFS) — 5.8; 6.1; 6.6 years — p=0.80
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders
Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
Dermatitis, Atopic Dermatitis
Primary: Percentage Change From Baseline in the Eczema Area and Severity Index (EASI) Score at Week 12. — -10.98; -25.99; -31.57 percent change — p=0.1308
Pancreatic Cancer
Primary: Rate of Margin Negative Surgical Resection (R0 Resection Rate) — 88 percentage of participants